Serum tumor markers in bile duct cancer--a review

Biomarkers. 2014 Sep;19(6):437-43. doi: 10.3109/1354750X.2014.923048. Epub 2014 May 23.

Abstract

Context: Bile duct cancer (BDC) is a disease with a very grave prognosis, often diagnosed too late.

Objective: The aim of this review is to evaluate available literature on tumor markers in serum from patients with BDC.

Methods: Using the search words "serum markers", "bile duct cancer", "cholangiocarcinoma", "biomarker" and "tumor marker", a search was carried out.

Results: Seventy-five studies were included in the review.

Conclusion: CA19-9 is by far the most studied and most promising diagnostic and/or prognostic marker in BDC. But also the different mucins are interesting as new markers of BDC in serum.

Keywords: Bile duct cancer; biomarker; cholangiocarcinoma; diagnosis; prognosis; serum.

Publication types

  • Review

MeSH terms

  • Bile Duct Neoplasms / blood*
  • Bile Duct Neoplasms / diagnosis
  • CA-19-9 Antigen / blood*
  • Carcinoembryonic Antigen / blood*
  • Humans
  • Mucins / blood

Substances

  • CA-19-9 Antigen
  • Carcinoembryonic Antigen
  • Mucins